Cargando…
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study
Existing tools for post-radical prostatectomy (RP) prostate cancer biochemical recurrence (BCR) prognosis rely on human pathologist-derived parameters such as tumor grade, with the resulting inter-reviewer variability. Genomic companion diagnostic tests such as Decipher tend to be tissue destructive...
Autores principales: | Leo, Patrick, Janowczyk, Andrew, Elliott, Robin, Janaki, Nafiseh, Bera, Kaustav, Shiradkar, Rakesh, Farré, Xavier, Fu, Pingfu, El-Fahmawi, Ayah, Shahait, Mohammed, Kim, Jessica, Lee, David, Yamoah, Kosj, Rebbeck, Timothy R., Khani, Francesca, Robinson, Brian D., Eklund, Lauri, Jambor, Ivan, Merisaari, Harri, Ettala, Otto, Taimen, Pekka, Aronen, Hannu J., Boström, Peter J., Tewari, Ashutosh, Magi-Galluzzi, Cristina, Klein, Eric, Purysko, Andrei, NC Shih, Natalie, Feldman, Michael, Gupta, Sanjay, Lal, Priti, Madabhushi, Anant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093226/ https://www.ncbi.nlm.nih.gov/pubmed/33941830 http://dx.doi.org/10.1038/s41698-021-00174-3 |
Ejemplares similares
-
A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI
por: Li, Lin, et al.
Publicado: (2020) -
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study
por: Falagario, Ugo, et al.
Publicado: (2020) -
Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer
por: Li, Lin, et al.
Publicado: (2023) -
(11)C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
por: Salminen, Antti, et al.
Publicado: (2018) -
Prediction of prostate cancer aggressiveness using (18)F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI
por: Movahedi, Parisa, et al.
Publicado: (2020)